АШУҮИС — Судалгааны мэдээлэл (CRIS)
Permanent URI for this communityhttps://library.mnums.edu.mn/handle/123456789/5001
Browse
6 results
Search Results
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Disability of stroke by its sybtypes in the population of Ulaanbaatar, Mongolia(Elsevier BV, 2023-12-01); ; ; ; Tuguldur Erdenedalai - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Causes and Risk Factors for Early Neonatal Mortality in the Western Region of Mongolia(Mongolian National University of Medical Sciences, 2015-09-25) ;Solongo Tsedev; ;Gerelmaa ZagdBurmaajav BadrakhObjectives: The incidence of perinatal, especially early neonatal mortality, has not been reducing in the western region of Mongolia, therefore, the purpose of this study was to identify causes and risk factors for early neonatal mortality in the western region of Mongolia. Methods: A case-control study for neonatal mortality was conducted in 5 hospitals in western Mongolia in 2014. Cases and controls were chosen from the hospitals. Associated causes and risk factors for early neonatal mortality were identified with subgroup binary logistic regression analyses. Results: A total of 7749 live births occurred during the study period. The early neonatal mortality rate was 11.3 per 1000 births. Obstetric complications, obstetric chronic history, abruption of placenta, preeclampsia and maternal diseases influenced early neonatal mortality. Respiratory distress syndrome (OR=29.4; 95% CI, 12.78-67.65, p<0.05), perinatal asphyxia (OR=5.2; 95% CI, 2.81-9.63, p≤0.001), congenital malformation (OR=39.2; 95% CI, 5.11-302.1) and perinatal infections (OR =11.1; 95% CI, 3.64-34.28, p≤0.001) were the leading causes of newborn death in the first week. Conclusion: Overall, high rates of neonatal death demonstrate the need to improve the quality of health care and the control of delivery and factors influencing early neonatal mortality should be studied further at the national level.> - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Antiviral Efficacy and Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate in the Treatment of Chronic Hepatitis B(Mongolian National University of Medical Sciences, 2020-12-29); ;Amaraa Ravdan ;Gegeebadrakh Baljinnyam ;Burmaajav BadrakhObjectives: To provide compare of the efficacy and safety tenofovir alafenamide (TAF) to tenofovir disoproxil fumarate (TDF) in patients with HBeAg-negative and HBeAg-positive chronic hepatitis B. Methods: We performed a randomized, unblinded, non-inferiority study in which patients with compensated cirrhosis (Child-Pugh A and B stage) between 18-70 years old with a positive chronic hepatitis B test were randomized to receive either TAF, TDF, or were switched from TDF to TAF. The primary efficacy endpoint was the proportion of patients with HBV-DNA < 29 IU/ml at week 48. Results: The efficacy endpoint, an HBV-DNA < 29 IU/ ml at weeks 48, was achieved by 251 (79.9 %) of 314 patients receiving TAF, which was not significantly different from the 113 (74.8 %) of 151 patients receiving TDF. After 48 weeks of treatment, patients receiving TAF had significantly smaller bone mineral density reductions than patients receiving TDF. At week 48, the median decrease in eGFR was significantly less in the TAF recipients than the TDF recipients. Conclusion: TAF treatment has the same efficacy as TDF treatment. However, TAF treatment had a better safety profile than TDF. Patients receiving TAF had a significantly smaller median decrease in the eGFR by the Cockcroft-Gault equation than patients receiving TDF. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Some Associations of Primary Headache Disorders in Mongolia: A Nationwide Population-Based Study(Mongolian National University of Medical Sciences, 2019-12-29) ;Byambasuren Tsenddorj ;Dorjkhand Baldorj ;Delgermaa Purev; Objective: Headache disorders are the most prevalent public-health problem, affecting people in all countries. Epidemiological data on headaches are not available in Mongolia. Our study aimed to estimate the prevalence of each headache disorders of public health importance and examine their socio-demographic associations, in urban and rural areas. Methods: There were 2,043 biologically unrelated adults (aged 18–65 years) in a door to door survey randomly sampled from Ulaanbaatar (capital of Mongolia) and four aimags (rural), and interviewed by trained researchers using a pilot-tested, validated, structured questionnaire. ICHD-II diagnostic criteria were applied. Results: The observed prevalence of any headache was 66.1%, with a female preponderance of 2:1. The age-standardized prevalence of migraines was 24.2%; prevalence was higher among females than males (OR 2.4, 95% CI 1.9; 2.9, p = .0001), and among those with high education (OR 3.0, 95% CI 1.5; 5.8, p = .002). The age-standardized prevalence of tension-type headache was 29.0%, higher among younger people. The estimated prevalence of all headaches on ≥15 days/month was 11.2% (that of probable medication-overuse headaches was about 70%). Conclusion: The prevalence of primary headaches was 63.9%, with migraines being 24.2%, and tension-type headaches 29.0%. Female gender, higher education level, and family history were associated risk factors for primary headaches. There was a relatively high prevalence of headaches on ≥15 days/month and those with probable medication overuse headaches. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Prevalence of Blue Spot among Mongolian Newborn Infants(Mongolian National University of Medical Sciences, 2017-11-25) ;Suvd Batbaatar; ;Lkhamsuren Sonom ;Oyunchimeg UnshigbayarMyagmarjav SharkhuuObjectives: The aim of this study was to determine the prevalence and characteristics of Mongolian spots in Mongolian infants. Methods: This hospital-based, descriptive cross-sectional study was conducted nationwide among 2641 newborn infants in Ulaanbaatar and in 21 provinces hospitals within 96 hours postpartum in 2015. Results: The prevalence of Mongolian spots in Mongolian infants was 91.3%. The prevalence of spots in females was 92.1% and in male newborns it was 90.6% (p>0.05). The prevalence of Mongolian spots in the Western provinces was lower than in the rest of other provinces (98.3% and 95% CI: 96.4-99.4). For of infants with Khalkha parentage, 92.7% had Mongolian spots, while 64.7% of infants with Kazakh parentage had Mongolian spots. The Mongolian spots are commonly located in infant’s lower back (88.3%) and had an average length of 3.7±2.7 cm, width of 2.7±1.9 cm and an average area of 14.2±23.3 cm2. The appearance of Mongolian spots on the infant’s legs, face, chest, hands, feet, knee, and cheeks were less frequent. Conclusion: The prevalence of Mongolian spots among Mongolian infants was 91.3% [95%CI: 87.2-95.3] and significant difference was observed between Mongolian and Kazakh infants. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Knowledge, Attitudes, and Practices (KAP) Regarding Hepatitis B Vaccination among Healthcare Workers in Mongolia(Scientific Research Publishing, 2023-01-01); ;Burmaajav Badrakh; ;Byambaa TumurbatBadamjav AmgalanBackground: Mongolia is no exception and experiencing the burden of HBV among the population. In the last decade, the prevalence of HBV among the relatively healthy population of Mongolia has ranged between 11.8 percent and 10.6 percent, and acute cases are between 1.7 and 1.1 per 10,000 people. We aimed to determine healthcare workers (HCWs) knowledge, attitude, and practices regarding HBV prevention compared to vaccination coverage. Methods: This cross-sectional study was conducted among HCWs from the selected sites through multi-stage sampling. The study involved 1135 HCWs, including medical doctors, nurses, clinicians in both surgical and medical specialties, laboratory technicians, and other staff working in all departments from primary and referral levels in 36 healthcare facilities in two urban and four rural provinces of Mongolia. Participants who consented to the study completed a standardized self-administered questionnaire between July and Dec 2019. Results: Most participants (82.0%) were born before 1992 or before starting a birth vaccination against HBV in Mongolia. The mean age of the participants was 38 years and the participants’ median employment year in the health sector was seven years. Most participants were medical doctors (29.1%) and nurses (28.0%). Five questions explored HCWs’ knowledge about hepatitis B virus infection and prevention, and the correct response ranged between 15.6% and 95.4%. 2.8% of the respondents answered five questions correctly. Men, those with higher levels of education, those over the age of 30, soum family health center HCWs, and doctors and senior medical professionals answered many questions correctly, which is statistically significant. 98.9% of respondents believe that HCWs should vaccinate against HBV. The younger the age (%), management professionals, and service staff are confident in vaccines. A significant difference between age groups, perception of HBV infection, and formal attendance to the official training positively relate to vaccination coverage. Specially survey respondents who knew about the adverse effects of overdosing, learning about total doses of the vaccine, and the effectiveness of the hepatitis B vaccine were more tent to have full doses of the HBV vaccine. Knowledge and working conditions are increasing factors in receiving full doses of the HVB vaccine. Conclusion: The overall knowledge of HBV and its vaccination is fair among the HCWs; however, there is a need to intensify the training on some of the details and increase the training frequency at the workplace. Attitude and practice on infection protection and vaccination are still essential to be promoted among the HCWs. The low level of vaccination coverage is relevant to the level of KAP among the HCWs of the country.
